Medicine Debate Gives Bitter Taste to WTO Conference Inter Press Service
click here to return to Inter Press Service main menu
DonateNow


Medicine Debate Gives Bitter Taste to WTO Conference

Inter Press Service - November 7, 2001
Gustavo Capdevila


DOHA, Nov 7 (IPS) - Intellectual property rules that obsruct poor countries' access to medicine will be a crucial issue at the Fourth Ministerial Conference of the World Trade Organisation (WTO), to begin Friday in the Qatar capital. Several countries threaten to boycott future trade talks if the matter is not resolved, say activists.

Keith Rockwell, WTO press director, acknowledged last week that without an agreement to settle the conflict between patent rights and access to low-cost medications there will be no ministerial declaration, the conference's final objective.

Developing countries, led by a bloc of African nations, are pushing for a special declaration from the conference that interprets existing trade rules in such a way that it confirms the right of governments to ensure access to medications for their populations.

But the United States and Switzerland, home to the largest pharmaceutical transnationals, oppose an explicit declaration because they say current standards grant poor countries sufficient freedoms to protect public health.

Increasing pressure has been exerted on developing countries in the last few days to convince them to change their stance on the matter, said attorney Severina Rivera, who arrived in Doha as a representative of the US office of Oxfam, a Britain-based non- governmental organisation (NGO) dedicated to humanitarian efforts.

Rivera said that US Trade Representative Roberto Zoellick took advantage of a meeting last week in Washington with his African counterparts to pressure them to agree to Washington's agenda on pharmaceuticals and property rights in exchange for what she said were ''little rewards.''

The United States threatened to withdraw certain grants and aid programmes, and used the threat ''to break the unity among the different African countries,'' said the Oxfam delegate.

Zoellick used the same approach with Central American and Caribbean countries, also offering them ''small benefits and loans,'' according to Rivera, who said her information was based on statements received from members of the US Congress.

The NGOs arriving in Qatar, which promise intense lobbying efforts aimed at the delegates of the WTO's 142 member states, say that the position of the developing countries is short-sighted and that they are wasting an unprecedented opportunity in Doha to reform the global system of drug-related patents.

The final declaration on intellectual property and health must establish that vital medicines cannot be sold at prices that are beyond the means of poor countries, said the Oxfam representative.

In the draft of the ministerial conference's final declaration, written by chairman of the WTO General Council, Stuart Harbison, ambassador from Hong Kong, the section on access to medication contains two options for the interpretation of the existing policy, detailed under the Agreement on Trade-Related Aspects of Intellectual Property Rights, known as TRIPS.

Option One states that ''nothing in the TRIPS agreement shall prevent embers from taking measures to protect public health.''

Accordingly, the TRIPS agreement ''shall be interpreted and implemented in a manner supportive of WTO members' right to protect public health and, in particular, to ensure access to medicines for all,'' reads the first alternative in the draft document.

The text also reaffirms the right of WTO members ''to use, to the full, the provisions in the TRIPS agreement'' that permit flexibility in obtaining access to pharmaceuticals.

The second option in the draft declaration limits the flexibility of the TRIPS agreement to situations of public health crises, such as HIV/AIDS and other pandemics. It further clarifies that the declaration ''does not add or diminish the rights and obligations'' of WTO members stipulated in that agreement. Oxfam's Rivera commented that the first option does not reflect the position of developing countries as it was claimed to do.

The text, she said, ''does not have what developing countries want, which is a reaffirmation that they have the widest options possible to employ all policy options for public health concerns.''

The draft limits policy options to public health crises and national emergencies and ignores other diseases associated with poverty, such as tuberculosis and malaria, which are very widespread, though do not necessarily rise to the same level of national emergency as HIV/AIDS does, according to Rivera.

She added that several countries, the African nations and India among them, were threatening to leave the WTO because of this dispute.

Ali Mchumo, Tanzania's ambassador before the WTO and spokesman in Geneva for the group of Least Developed Countries, charged that the industrialised countries are pressing for a more restrictive text on the flexibility of the TRIPS agreement to the detriment of the world's developing countries.


011107
IP011103


Copyright © 2001 - Inter Press Service. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Inter Press Service, IPS-ONLINE, World Desk via Panisperna 207 00184 Rome, Italy. Email: info@ips.org  http://www.ips.org

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .